Joyn Bio Stock
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
Sign up today and learn more about Joyn Bio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Joyn Bio Stock
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.
Funding History
| March 2018 | $100M |
|---|
Management
Co-Founder
Jason Kelly
Press
cnbc - May, 22 2022
Joyn Bio aims to solve the world’s fertilizer problem with microbesbizjournals - Nov, 13 2021
Joyn Bio expands Woodland ag-tech research operationnanalyze - Aug, 29 2021
4 Companies Replacing Nitrogen in Fertilizersfinance - Feb, 23 2021
“One of the challenges is we have products that farmers are using and many of these products are not sustainable” : Joyn Bio CEOnanalyze - Jun, 8 2019
How Plant Sciences Will Feed 10 Billion People By 2050EquityZen Recognized As:
